首页 > 市场调查报告书 > 食物/饮料

食品添加剂机能性食品

市场调查报告书

商品编码

1761813

全球 CROCIN 市场研究报告 - 产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

Global CROCIN Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年07月01日 | 出版商:

Value Market Research | 英文 152 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计全球 CROCIN 市场规模将从 2024 年的 57.2 亿美元成长到 2033 年的 94.3 亿美元，在 2026 年至 2033 年的预测期内，年复合成长率(CAGR) 将达到 5.72%。

藏红花素市场涵盖药物化合物藏红花素的生产和分销，由于发烧和疼痛相关疾病的日益流行，该市场正在经历显着增长。藏红花素以其对乙酰氨基酚为基础的镇痛和解热功效而闻名，广泛应用于家庭和医疗保健领域。随着消费者健康意识的不断提高，越来越多的消费者选择使用藏红花素等非处方药来快速缓解常见疾病。这一趋势推动了对藏红花素产品的需求，为未来几年市场强劲成长奠定了基础。

此外，随着消费者寻求有效解决方案来管理各种疾病相关症状，预防性医疗保健日益受到重视，这也影响了藏红花素 (CROCIN) 市场。尤其是在发展中地区，自我药疗的兴起促进了藏红花素及类似产品的销售成长。由于医疗保健系统在提供及时医疗服务方面面临挑战，有效的非处方药供应变得至关重要。这一趋势促使製造商增强产品供应，专注于满足特定消费者需求的配方，例如儿科配方和针对多种症状的复合产品。

此外，製药业的数位转型正在重塑 CROCIN 市场。电商平台和远距医疗服务让消费者更轻鬆地在家中舒适地取得包括 Crocin 在内的药物。这种转变在新冠疫情之后尤其重要，疫情加速了线上医疗解决方案的普及。随着市场的不断发展，健康意识的增强、自我药疗的兴起以及数位分销管道的增长，这些因素共同推动了 CROCIN 市场的持续增长，满足了消费者寻求有效缓解疼痛和发烧的多样化需求。

我们的报告经过精心设计，旨在为客户提供关于各个行业和市场的全面且切实可行的洞察。每份报告都包含几个关键部分，以确保客户全面了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本部分探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准，将市场细分为不同的细分市场。此分析重点在于突出每个细分市场的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本部分深入分析了竞争态势以及领先公司采用的关键策略。

市场预测：根据历史资料和当前市场状况，对特定时期的市场规模和成长趋势进行预测。这包括定量分析和图形表示，以说明未来的市场发展轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前及新兴市场趋势、技术创新以及潜在投资领域。本部分将深入探讨未来市场发展与成长前景。

区域展望
介绍
北美销售分析
- 概述、历史和预测数据销售分析
- 北美各细分市场销售分析
- 北美各国销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概述、历史和预测数据销售分析
- 欧洲各细分市场销售分析
- 欧洲各国销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概述、历史和预测数据销售分析
- 亚太地区分部销售分析
- 亚太地区国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概述、历史和预测数据销售分析
- 拉丁美洲各细分市场销售分析
- 拉丁美洲各国销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概述、历史和预测数据销售分析
- 中东和非洲分部销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东和非洲其他地区销售分析

第 10 章：CROCIN 公司的竞争格局

CROCIN市场竞争
合作/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

顶级公司市占率分析
市场集中度
TCI Chemicals Pvt. Ltd.

公司概况
公司收入
产品
最新动态

Merck KGaA

公司概况
公司收入
产品
最新动态

GSK Plc.

公司概况
公司收入
产品
最新动态

Cayman Chemical

公司概况
公司收入
产品
最新动态

APExBIO Technology

公司概况
公司收入
产品
最新动态

Wilshire Technologies

公司概况
公司收入
产品
最新动态

Biosynth

公司概况
公司收入
产品
最新动态

Cipla Inc.

公司概况
公司收入
产品
最新动态

Novartis AG

公司概况
公司收入
产品
最新动态

Sanofi

公司概况
公司收入
产品
最新动态

Aurobindo Pharma

公司概况
公司收入
产品
最新动态

Teva Pharmaceutical Industries Ltd.

公司概况
公司收入
产品
最新动态

Mallinckrodt

公司概况
公司收入
产品
最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

简介目录图表

Product Code: VMR11214564

Global CROCIN Market size is anticipated to grow from USD 5.72 Billion in 2024 to USD 9.43 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 5.72% during the forecast period of 2026 to 2033.

The CROCIN market, which encompasses the production and distribution of the pharmaceutical compound Crocin, is witnessing significant growth due to the increasing prevalence of fever and pain-related ailments. Crocin, known for its efficacy as a paracetamol-based analgesic and antipyretic, is widely used in households and healthcare settings. As awareness of health and wellness continues to rise, consumers are increasingly turning to over-the-counter medications like Crocin for quick relief from common ailments. This trend is driving demand for Crocin products, positioning the market for robust expansion in the coming years.

Moreover, the growing emphasis on preventive healthcare is influencing the CROCIN market, as consumers seek effective solutions for managing symptoms associated with various conditions. The rise of self-medication, particularly in developing regions, is contributing to increased sales of Crocin and similar products. As healthcare systems face challenges in providing timely access to medical care, the availability of effective over-the-counter medications becomes crucial. This trend is prompting manufacturers to enhance their product offerings, focusing on formulations that cater to specific consumer needs, such as pediatric formulations and combination products that address multiple symptoms.

Additionally, the digital transformation of the pharmaceutical industry is reshaping the CROCIN market. E-commerce platforms and telemedicine services are making it easier for consumers to access medications, including Crocin, from the comfort of their homes. This shift is particularly relevant in the wake of the COVID-19 pandemic, which has accelerated the adoption of online healthcare solutions. As the market continues to evolve, the combination of increasing health awareness, the rise of self-medication, and the growth of digital distribution channels positions the CROCIN market for sustained growth, meeting the diverse needs of consumers seeking effective pain and fever relief.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Application

Food
Chemical Industry
Drug
Others

By Purity

Purity >98%
Purity <98%

By Indication

Pain
Pyrexia (Fever)

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CROCIN INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Purity
- 3.7.3 Market Attractiveness Analysis By Indication
- 3.7.4 Market Attractiveness Analysis By Distribution Channel
- 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CROCIN MARKET ANALYSIS BY APPLICATION

5.1. Overview By Application
5.2. Historical and Forecast Data Analysis By Application
5.3. Food Historic and Forecast Sales By Regions
5.4. Chemical Industry Historic and Forecast Sales By Regions
5.5. Drug Historic and Forecast Sales By Regions
5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL CROCIN MARKET ANALYSIS BY PURITY

6.1. Overview By Purity
6.2. Historical and Forecast Data Analysis By Purity
6.3. Purity >98% Historic and Forecast Sales By Regions
6.4. Purity <98% Historic and Forecast Sales By Regions

7. GLOBAL CROCIN MARKET ANALYSIS BY INDICATION

7.1. Overview By Indication
7.2. Historical and Forecast Data Analysis By Indication
7.3. Pain Historic and Forecast Sales By Regions
7.4. Pyrexia (Fever) Historic and Forecast Sales By Regions

8. GLOBAL CROCIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL

8.1. Overview By Distribution Channel
8.2. Historical and Forecast Data Analysis By Distribution Channel
8.3. Hospital Pharmacy Historic and Forecast Sales By Regions
8.4. Retail Pharmacy Historic and Forecast Sales By Regions
8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL CROCIN MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CROCIN COMPANIES

10.1. CROCIN Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF CROCIN INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. TCI Chemicals Pvt. Ltd.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Merck KGaA
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. GSK Plc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Cayman Chemical
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. APExBIO Technology
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Wilshire Technologies
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Biosynth
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Cipla Inc.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Novartis AG
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Sanofi
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Aurobindo Pharma
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Teva Pharmaceutical Industries Ltd.
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
11.15. Mallinckrodt
- 11.15.1 Company Overview
- 11.15.2 Company Revenue
- 11.15.3 Products
- 11.15.4 Recent Developments